United States· US:21586-011_425c90b3-5006-427e-95f6-93ee7918fb8b

Cefotaxime

A third-generation cephalosporins product containing cefotaxime injection, registered in United States by SteriMax Inc..

In shortageATC J01DDUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCefotaximeATCJ01DDREGISTER NO.US:21586-011_425c90b3…PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
cefotaxime injection
Manufacturer
SteriMax Inc.
Country
United States (US)
ATC code
J01DD
ATC class
Third-generation cephalosporins
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 1

  • ndc11
    2158601102
    10 VIAL in 1 PACKAGE (21586-011-02) / 1 POWDER, FOR SOLUTION in 1 VIAL (21586-011-01)

Regulatory notes

UNII (FDA substance ID)
258J72S7TZ
CEFOTAXIME SODIUM
RxCUI 203117
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Cefotaxime Sodium Powder, for Solution

Same medicine, other countries

Cefotaxime injection in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefotaxime injection products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Cefotaxim Aptapharma, Cefotaxim Eberth
  • Belgium · Cefotaxime Noridem, Claforan
  • Bulgaria · Валоран, Тенатаксим
  • Cyprus · Oximezin, Syntoxime
  • Czechia · Cefotaxim Hameln, Cefotaxime Swyssi
  • Germany · Cefotaxim Eberth, Cefotaxim Fresenius
  • Denmark · Cefotaxim "hameln", Cefotaxim Mip
  • Estonia · Cefotaxime Mip, Valoran
  • Spain · Cefotaxima Normon, Cefotaxima Sala
  • Finland · Cefotaxim Hameln, Cefotaxim Mip Pharma
  • France · Cefotaxime Noridem, Cefotaxime Panpharma
  • United Kingdom (Northern Ireland) · Cefotaxime Cox Pharmaceutical, Cefotaxime Hameln Pharma
  • Greece · Ciltiren, Gloryfen
  • Croatia · Cefotaksim Aptapharma, Cefotaksim Mip
  • Hungary · Cefotaxim Aptapharma, Cefotaxime Swyssi
  • Ireland · Cefotaxime Hameln, Cefotaxime Noridem Enterprises
  • Iceland · Cefotaxim Navamedic
  • Italy · Batixim, Cefotaxim Hameln
  • Lithuania · Cefotaxime Mip
  • Luxembourg · Cefotaxime Noridem, Claforan
  • Latvia · Cefotaxime Mip
  • Malta · Valoran
  • Netherlands · Cefotaxim Hameln
  • Norway · Cefotaxim Hameln, Cefotaxim Mip
  • Poland · Biotaksym, Cefotaxim Mip
  • Portugal · Antadar, Antadar I.M.
  • Romania · Cefotax, Cefotaxim Mip
  • Sweden · Cefotaxim Hameln, Cefotaxim Mip
  • Slovenia · Cefotaksim Aptapharma, Valoran
  • Slovakia · Cefotaxim Eberth, Cefotaxime Hameln

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6fe375e1-d1d1-4712-891f-7cb5daeb9a6a
GET /v1/drugs/6fe375e1-d1d1-4712-891f-7cb5daeb9a6a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "258J72S7TZ",
    "rxcui": "203117",
    "inchikey": "AZZMGZXNTDTSME-JUZDKLSSSA-M",
    "display_name": "CEFOTAXIME SODIUM",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "INTRAMUSCULAR; INTRAVENOUS",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 4
  },
  "spl_meta": {
    "8efe3bd0-c43a-2bd6-e053-2a95a90a92fa": {
      "match": "brand_token",
      "title": "CEFOTAXIME (CEFOTAXIME INJECTION) POWDER, FOR SOLUTION [STERIMAX INC.]",
      "spl_version": "6",
      "published_date": "2024-12-16"
    }
  },
  "productid": "21586-011_425c90b3-5006-427e-95f6-93ee7918fb8b",
  "productndc": "21586-011",
  "dosage_form": "POWDER, FOR SOLUTION",
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "CEFOTAXIME SODIUM",
  "shortage_reason": "Cefotaxime Sodium Powder, for Solution",
  "shortage_status": "current",
  "proprietary_name": "Cefotaxime",
  "active_ingred_unit": "g/1",
  "application_number": null,
  "marketing_category": "UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE",
  "nonproprietary_name": "cefotaxime injection",
  "start_marketing_date": "20190801",
  "active_numerator_strength": "1"
}

See everything about cefotaxime injection.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.